Skip to content

Application of threaded tube in atomisation inhalation

Application of threaded tube in atomisation inhalation for patients undergoing non-mechanical ventilation with endotracheal intubation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN73052288
Enrollment
105
Registered
2024-10-31
Start date
2020-03-03
Completion date
Unknown
Last updated
2024-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atomisation inhalation for patients undergoing non-mechanical ventilation with endotracheal intubation Injury, Occupational Diseases, Poisoning

Interventions

Comatose patients undergoing non-mechanical tracheal ventilation were included and divided into two groups: the experimental group (n = 56) and the control group (n = 49). The experimental group was p

Sponsors

Second Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18-88 years old 2. Comatose patients undergoing non-mechanical ventilation with endotracheal intubation 3. Patients whose condition could tolerate atomisation inhalation before an operation 4. Patients whose guardians agreed to participate in this trial and provided written informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with an endotracheal intubation retention time of <5 days 2. Patients who underwent endotracheal intubation and switched to mechanical ventilation on days 1 to 5 3. Patients who underwent mechanical ventilation before switching to non-mechanical ventilation after endotracheal intubation 4. Patients who were intubated and then changed to tracheotomy within 5 days 5. Patients with respiratory failure, heart failure and/or severe liver and kidney diseases 6. Patients with acute respiratory failure or acute renal injury

Design outcomes

Primary

MeasureTime frame
The following primary outcome measures were assessed at time points on days 1-5 after humidification: 1. Sputum viscosity is evaluated by clinical doctors based on standardized grading scales 30 minutes after each nebulization session, with assessments carried out twice daily 2. Sputum pH value measured using pH test paper and comparison with the acid-base colorimetric card 30 minutes after each nebulization session, with assessments carried out twice daily

Secondary

MeasureTime frame
The following secondary outcome measures were assessed at time points on days 1-5 after humidification: 1. Airway mucosal bleeding measured by observation of airway mucosal bleeding was conducted 30 minutes after each nebulization session, with assessments carried out twice daily 2. Sputum scab formation measured using data recording observations of resistance during the insertion of the conventional suction catheter, small sputum scabs inside the suction catheter during suctioning and/or sputum scabs on the suction catheter during suctioning 4 hours after each nebulization session, with assessments carried out twice daily 3. Respiratory patency measured using a combination of physical examination, including observation and auscultation, the analysis of capnography and ventilator settings to ensure a comprehensive evaluation of airway obstruction and ease of breathing 4 hours after each nebulization session, with evaluations carried out twice daily 4. Pulmonary infection measured by conducting bedside lung ultrasound assessments at a fixed time each day, specifically at 18:00, to provide more continuous and dynamic monitoring of the patient’s pulmonary infection status

Countries

China

Contacts

Public ContactLiqiao Zhang
liqiao_zhang@126.com+86 0311-66002999

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026